Lantern Pharma (LTRN) Expected to Announce Earnings on Monday
Lantern Pharma (NASDAQ:LTRN – Get Free Report) is expected to be announcing its earnings results before the market opens on ...
MyChesCo on MSN7h
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of ...
The Manila Times8h
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...
Cyclo Therapeutics (CYTH) to Release Earnings on Monday
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Monday, March 17th. Analysts expect Cyclo Therapeutics to post ...
Targeted Oncology8h
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...
TipRanks on MSN19h
MoonLake Immunotherapeutics Advances Clinical Trials in 2024
Moonlake Immunotherapeutics ( ($MLTX) ) has released its Q4 earnings. Here is a breakdown of the information Moonlake Immunotherapeutics presented ...
Sanofi: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...